Benzinga's Volume Movers

Loading...
Loading...
Neurocrine Biosciences
NBIX
shares moved up 76.95% to $17.27. The volume of Neurocrine Biosciences shares traded was 4406% higher than normal. Neurocrine Biosciences reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study. Epizyme
EPZM
shares rose 66.84% to $34.20. The volume of Epizyme shares traded was 1683% higher than normal. Epizyme reported two major milestone achievements. It announced the achievement of a proof of concept milestone in the EPZ-5676 DOT1L inhibitor clinical program. ANI Pharmaceuticals
ANIP
shares climbed 9.42% to $20.79. The volume of ANI Pharmaceuticals shares traded was 651% higher than normal. ANI Pharmaceuticals shares have jumped 121.45% over the past 52 weeks, while the S&P 500 index has surged 25.37% in the same period. Cray
CRAY
surged 14.40% to $31.07. The volume of Cray shares traded was 649% higher than normal. Cray affirmed its revenue outlook for 2013 and 2014.
Posted In: NewsIntraday UpdateMarketsMoversBiotechnologyHealth Carevolume movers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...